Heat Biologics Inc (HTBX)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

627 DAVIS DRIVE MORRISVILLE, NC 27560

Heat Biologics, Inc. is a biopharmaceutical company. The Company develops drugs to treat a variety of cancers, viral, and autoimmune diseases. Heat Biologics manufactures antibodies to treat asthma, inflammatory bowel disease, and rheumatoid arthritis.

Data as of 2021-05-08 11:23:13 -0400
Market Cap157.833 Million Shares Outstanding25.253 Million Avg 30-day Volume396.32 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.48962 52-week High/Low30.1 / 3.71 Next Earnings Date2021-08-05 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from HTBX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 37 45 -17.78% 7 (0.42%) 8 (0.5%) -12.5%
13F shares: 2.322 Million 1.624 Million 43.0% 299.42 Thousand 186.833 Thousand 60.26%
% Ownership 10.1705 1.0159 901.13% 1.3114 0.1169 1021.81%
New Positions: 9 30 -70.0% 3 5 -40.0%
Increased Positions 10 9 11.11% 2 3 -33.33%
Closed Positions 16 10 60.0% 4 3 33.33%
Reduced Positions 16 4 300.0% 2
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding HTBX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HTBX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WOLF JEFFREY ALAN CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
787,740 2021-01-04 3

SMITH EDWARD B III

  • Director
0 2021-01-04 2

MONAHAN JOHN J

  • Director
0 2021-01-04 1

PRENDERGAST JOHN K A

  • Director
238,272 2021-01-04 1

OSTRANDER WILLIAM L. CFO/CORP SECY

  • Officer
0 2021-01-04 2

HUTCHINS JEFF TOBIN CSO AND COO

  • Officer
0 2020-03-12 0

JAKOBS ROBERT JAMES VP FINANCE/CONTROLLER/SECTY

  • Officer
0 2019-04-01 0

ROSAR ANN A VP OF FINANCE

  • Officer
93,379 2019-01-01 0

KHARITONOV MICHAEL

  • Director
949,960 2016-03-23 0

SCHREIBER TAYLOR CHIEF SCIENTIFIC OFFICER

  • Officer
0 2016-01-11 0

GOYAL ANIL K. VP OF BUSINESS DEVELOPMENT

  • Officer
0 2016-01-11 0

PRICE MELISSA VP OF PRODUCT DEVELOPMENT

  • Officer
0 2016-01-11 0

BELSKY PAUL

  • Director
0 2016-01-11 0

BOCK LOUIS C

  • Director
0 2016-01-11 0

CREECH TIMOTHY J CHIEF FINANCIAL OFFICER

  • Officer
0 2015-11-30 0

DIPALMA STEPHEN J. INTERIM CFO

  • Officer
0 2015-03-09 0

ARISTAR CAPITAL MANAGEMENT, LLC

ARISTAR HEAT, LLC

ARISTAR CAPITAL MANAGEMENT GP, LLC

  • 10% Owner
697,303 2015-01-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
HEAT BIOLOGICS INC HTBX 2021-05-11 22:15:03 UTC -6.5664 6.6164 400000
HEAT BIOLOGICS INC HTBX 2021-05-11 21:45:03 UTC -6.5664 6.6164 400000
HEAT BIOLOGICS INC HTBX 2021-05-11 21:15:03 UTC -6.5664 6.6164 400000
HEAT BIOLOGICS INC HTBX 2021-05-11 20:45:03 UTC -6.5664 6.6164 400000
HEAT BIOLOGICS INC HTBX 2021-05-11 20:15:03 UTC -6.5664 6.6164 400000
HEAT BIOLOGICS INC HTBX 2021-05-11 19:45:03 UTC -6.5664 6.6164 400000
HEAT BIOLOGICS INC HTBX 2021-05-11 19:15:02 UTC -6.5664 6.6164 400000
HEAT BIOLOGICS INC HTBX 2021-05-11 18:45:02 UTC -6.5664 6.6164 400000
HEAT BIOLOGICS INC HTBX 2021-05-11 18:15:03 UTC -6.5664 6.6164 350000
HEAT BIOLOGICS INC HTBX 2021-05-11 17:45:03 UTC -6.5664 6.6164 350000
HEAT BIOLOGICS INC HTBX 2021-05-11 17:15:04 UTC -6.5664 6.6164 350000
HEAT BIOLOGICS INC HTBX 2021-05-11 16:45:04 UTC -6.5664 6.6164 350000
HEAT BIOLOGICS INC HTBX 2021-05-11 16:15:04 UTC -6.5664 6.6164 350000
HEAT BIOLOGICS INC HTBX 2021-05-11 15:45:03 UTC -6.5664 6.6164 250000
HEAT BIOLOGICS INC HTBX 2021-05-11 15:15:03 UTC -6.5664 6.6164 250000
HEAT BIOLOGICS INC HTBX 2021-05-11 14:45:03 UTC -6.8879 6.9379 250000
HEAT BIOLOGICS INC HTBX 2021-05-11 14:15:03 UTC -6.8879 6.9379 250000
HEAT BIOLOGICS INC HTBX 2021-05-11 13:45:04 UTC -6.8879 6.9379 250000
HEAT BIOLOGICS INC HTBX 2021-05-11 13:15:04 UTC -6.8879 6.9379 250000
HEAT BIOLOGICS INC HTBX 2021-05-11 12:45:03 UTC -6.8879 6.9379 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund HTBX -7228.0 shares, $-52619.84 2021-03-31 N-PORT

Elevate your investments